Wednesday, October 02, 2019 10:31:49 AM
InnerScope and Erchonia have entered into Joint Development & Exclusive Distribution Agreements and intend to obtain a 510k FDA-Clearance via clinical trial to study the effect on using Erchonia's Low-Level Laser Therapy Technology for the relief of tinnitus symptoms
https://www.globenewswire.com/news-release/2018/11/01/1641109/0/en/InnerScope-Hearing-Technologies-Inc-Erchonia-Corporation-to-Conduct-FDA-Clinical-Trial-for-the-Treatment-of-Tinnitus.html
Recent INND News
- InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com • InvestorsHub NewsWire • 04/24/2025 12:00:00 PM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
